Dean CL, Wade J, Roback JD. Transfusion-transmitted infections: an update on product screening, diagnostic techniques, and the path ahead. J Clin Microbiol. 2018;56(7):e00352-e418.
Staley E, Grossman BJ. Blood safety in the United States: prevention, detection, and pathogen reduction. Clin Microbiol Newsl. 2019;41(17):149–57.
Complete list of Donor Screening Assays for Infectious Agents and HIV Diagnostic Assays [Internet]. United States Food and Drug Administration. 2023 [cited 5 October]. Available from: https://www.fda.gov/vaccines-blood-biologics/complete-list-donor-screening-assays-infectious-agents-and-hiv-diagnostic-assays#Anti-T.%20Cruzi%20Assays%20(Detect%20antibodies%20to%20Trypanosome%20cruzi).
Bern C, Messenger LA, Whitman JD, Maguire JH. Chagas disease in the United States: a public health approach. Clin Microbiol Rev. 2019. https://doi.org/10.1128/CMR.00023-19.
CDC. Blood donor screening for Chagas disease–United States, 2006–2007. MMWR Morb Mortal Wkly Rep. 2007;56(7):141–3.
Leiby DA, Lenes BA, Tibbals MA, Tames-Olmedo MT. Prospective evaluation of a patient with Trypanosoma cruzi infection transmitted by transfusion. N Engl J Med. 1999;341(16):1237–9.
Stimpert KK, Montgomery SP. Physician awareness of Chagas disease, USA. Emerg Infect Dis. 2010;16(5):871–2.
Edwards MS, Abanyie FA, Montgomery SP. Survey of pediatric infectious diseases society members about congenital Chagas disease. Pediatr Infect Dis J. 2018;37(1):e24–7.
Irish A, Whitman JD, Clark EH, Marcus R, Bern C. Updated estimates and mapping for prevalence of chagas disease among adults, United States. Emerg Infect Dis. 2022;28(7):1313.
Garcia MN, Hernandez D, Gorchakov R, Murray KO, Hotez PJ. The 1899 United States kissing bug epidemic. PLoS Negl Trop Dis. 2015;9:e0004117.
Lynn MK, Bossak BH, Sandifer PA, Watson A, Nolan MS. Contemporary autochthonous human Chagas disease in the USA. Acta Trop. 2020;205:105361.
Gunter SM, Murray KO, Gorchakov R, Beddard R, Rossmann SN, Montgomery SP, et al. Likely autochthonous transmission of Trypanosoma cruzi to humans, South Central Texas, USA. Emerg Infect Dis. 2017;23(3):500–3.
Cantey PT, Stramer SL, Townsend RL, Kamel H, Ofafa K, Todd CW, et al. The United States Trypanosoma cruzi infection study: evidence for vector-borne transmission of the parasite that causes Chagas disease among United States blood donors. Transfusion. 2012;52(9):1922–30.
Forsyth CJ, Hernandez S, Flores CA, Roman MF, Nieto JM, Marquez G, et al. “You Don’t Have a Normal Life”: coping with chagas disease in Los Angeles. Calif Med Anthropol. 2021;40(6):525–40.
Forsyth C, Meymandi S, Moss I, Cone J, Cohen R, Batista C. Proposed multidimensional framework for understanding Chagas disease healthcare barriers in the United States. PLoS Negl Trop Dis. 2019;13(9):e0007447.
Manne-Goehler J, Reich MR, Wirtz VJ. Access to care for Chagas disease in the United States: a health systems analysis. Am J Trop Med Hyg. 2015;93(1):108–13.
Lynn MK, Dye-Braumuller KC, Beatty NL, Dorn PL, Klotz SA, Stramer SL, et al. Evidence of likely autochthonous Chagas disease in the southwestern United States: a case series of Trypanosoma cruzi seropositive blood donors. Transfusion. 2022. https://doi.org/10.1111/trf.17026.
Chagas Biovigilance Network [press release]. American Association of Blood Banks, February 14, 2020.
Garcia MN, Aguilar D, Gorchakov R, Rossmann SN, Montgomery SP, Rivera H, et al. Evidence of autochthonous Chagas disease in southeastern Texas. Am J Trop Med Hyg. 2015;92(2):325–30.
CDC. Antiparasitic Treatment 2021 [updated 14 June 2021. Available from: https://www.cdc.gov/parasites/chagas/health_professionals/tx.html
Meymandi S, Hernandez S, Park S, Sanchez DR, Forsyth C. Treatment of Chagas disease in the United States. Curr Treat Options Infect Dis. 2018;10(3):373–88.
Verani JR, Montgomery SP, Schulkin J, Anderson B, Jones JL. Survey of obstetrician-gynecologists in the United States about Chagas disease. Am J Trop Med Hyg. 2010;83(4):891–5.
Forsyth CJ, Hernandez S, Flores CA, Roman MF, Nieto JM, Marquez G, et al. “It’s like a phantom disease”: patient perspectives on access to treatment for Chagas disease in the United States. Am J Trop Med Hyg. 2018;98(3):735.
Nelson L, Trautman L, Nelson PB. Latino immigrants and rural gentrification: race, “illegality”, and precarious labor regimes in the United States. Ann Assoc Am Geogr. 2015;105(4):841–58.
Lichter DT. Immigration and the new racial diversity in rural America. Rural Sociol. 2012;77(1):3–35.
Passel J, Hugo Lopez M, Cohn DV. US Hispanic population continued its geographic spread in the 2010s. Washington: Pew Research Center; 2022.
Amstutz-Szalay S. Physician knowledge of Chagas disease in Hispanic immigrants living in Appalachian Ohio. J Racial Ethn Health Disparities. 2017;4:523–8.
Mahoney West H, Milliren CE, Manne-Goehler J, Davis J, Gallegos J, Perez JH, et al. Effect of clinician information sessions on diagnostic testing for Chagas disease. PLoS Negl Trop Dis. 2022;16(6):e0010524.
CDC. Diagnosis [updated April 11, 2022. Chagas Disease, Resources for Health Professionals, Diagnosis]. Available from: https://www.cdc.gov/parasites/chagas/health_professionals/dx.html
Whitman JD, Bulman CA, Gunderson EL, Irish AM, Townsend RL, Stramer SL, et al. Chagas disease serological test performance in US blood donor specimens. J Clin Microbiol. 2019;57(12):e01217-e1219.
Forsyth CJ, Manne-Goehler J, Bern C, Whitman J, Hochberg NS, Edwards M, et al. Recommendations for screening and diagnosis of Chagas disease in the United States. J Infect Dis. 2022;225(9):1601–10.
Bennett C, Straily A, Haselow D, Weinstein S, Taffner R, Yaglom H, et al. Chagas disease surveillance activities - seven states, 2017. MMWR Morb Mortal Wkly Rep. 2018;67(26):738–41.
UDH. Utah Reportable Diseases: Utah Department of Health; 2022 [updated 5 November 2022. Available from: https://epi.health.utah.gov/disease-reporting/
WSDOH. List of Notifiable Conditions WSDOH2022 [updated 12/2022. Available from: https://doh.wa.gov/public-health-provider-resources/notifiable-conditions/list-notifiable-conditions
LADPH. Reportable Diseases and Conditions 2023 [updated 7/24/2023. Available from: http://www.publichealth.lacounty.gov/acd/docs/ReportableDiseaseList.pdf
Harris N, Woc-Colburn L, Gunter SM, Gorchakov R, Murray KO, Rossmann S, et al. Autochthonous Chagas disease in the southern United States: a case report of suspected residential and military exposures. Zoonoses Public Health. 2017;64(6):491–3.
Beatty NL, Perez-Velez CM, Yaglom HD, Carson S, Liu E, Khalpey ZI, et al. Evidence of likely autochthonous transmission of Chagas disease in Arizona. Am J Trop Med Hyg. 2018;99(6):1534–6.
USFDA. Use of serological tests to reduce the risk of transmission of trypanosoma cruzi infection in blood and blood components: guidance for industry. In: Health USDo, Human Services F, Drug Administration CfBE, Research. New York: USFDA; 2017. p. 16.
Steele WR, Hewitt EH, Kaldun AM, Krysztof DE, Dodd RY, Stramer SL. Donors deferred for self-reported Chagas disease history: does it reduce risk? Transfusion. 2014;54(8):2092–7.
U.S. Blood Donation Statistics and Public Messaging Guide. America’s Blood Centers and Association for Blood Donor Professionals; 2024.
Stigler Granados P, Pacheco GJ, Núñez Patlán E, Betancourt J, Fulton L. Assessing the effectiveness of Chagas disease education for healthcare providers in the United States. BMC Infect Dis. 2020;20(1):743.
Meymandi SK, Hernandez S, Forsyth CJ. A community-based screening program for Chagas disease in the USA. Trends Parasitol. 2017;33(11):828–31.
Hochberg NS, Wheelock A, Hamer DH, Marcus R, Nolan MS, Meymandi S, et al. Chagas disease in the United States: a perspective on diagnostic testing limitations and next steps. Am J Trop Med Hyg. 2021;104(3):800.
Comments (0)